Depression News

Suicidal ideation appears similar between gun owners and non-gun owners when the probability of suicide is low, but when the probability rises, gun owners were less likely to endorse active means, researchers reported in JAMA Network Open.

The FDA has approved Neuronetics’ transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for adults with obsessive compulsive disorder.

CDC officials reported a historic increase of 35% in firearm homicides in 2020. This is the highest firearm homicide rate in the United States in more than 25 years, according to a CDC Vital Signs analysis.

SAN DIEGO — Social support and mindfulness practices can improve mental health in Hispanic pregnant women, according to a small study presented at the ACOG Annual Clinical & Scientific meeting.

The risk and rate of accumulating chronic conditions increased with diagnoses of depression and anxiety for both men and women, according to a study published in JAMA Network Open.

HHS has announced the launch of the Maternal Mental Health Hotline, a national, confidential, toll-free service for new and expecting mothers who are experiencing mental health challenges.

Through 12 months, psilocybin-assisted treatment showed to be safe and effective for major depressive disorder, researchers reported in the Journal of Psychopharmacology.

Fewer than half of emergency care visits for psychiatric reasons in postpartum women were accompanied by follow-up within 30 days, according to a study published in Lancet Psychiatry.

CHICAGO — In this video, Adrienne Youdim, MD, FACP, discusses the social factors driving the rising prevalence of obesity in the United States.

Italian-based biotech firm Stevanato Group and Bexson Biomedical Inc. announced a collaboration to treat a wide range of mental health issues with a subcutaneous drug-delivery device, including treatment-resistant depression and PTSD.